ScholarLens Back to search
2011•Digital Commons - PCOM (Philadelphia College of Osteopathic Medicine)Open access

Is Lenalidomide, in Combination with Dexamethasone, a Safe and Effective Treatment for Relapsed Multiple Myeloma?

Sarah Moncado

Open full text 0 citations

Abstract

OBJECTIVE: The objective of this systematic review is to determine whether or not lenalidomide, in combination with dexamethasone, is a safe and effective treatment for relapsed multiple myeloma.

Open-access reader

About this research paper

What this paper is about

OBJECTIVE: The objective of this systematic review is to determine whether or not lenalidomide, in combination with dexamethasone, is a safe and effective treatment for relapsed multiple myeloma.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE: The objective of this systematic review is to determine whether or not lenalidomide, in combination with dexamethasone, is a safe and effective treatment for relapsed multiple myeloma.

Key concepts: Lenalidomide, Dexamethasone, Multiple myeloma, Medicine, Thalidomide, Oncology, Carfilzomib, Internal medicine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Is Lenalidomide, in Combination with Dexamethasone, a Safe and Effective Treatment for Relapsed Multiple Myeloma? — Research Paper | ScholarLens